Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeadlam Regulatory News (HEAD)

Share Price Information for Headlam (HEAD)

Share Price is delayed by 15 minutes
Get Live Data
19.10    0.20 (1.06%)
Bid:
19.20
Ask:
19.85
Spread: 0.65 (3.385%)
Market Cap: £15.33m
HEAD Live PriceLast checked at - London Stock Exchange

Intraday Headlam Share Chart

Board Change

28 Feb 2025 07:00

RNS Number : 7894Y
Headlam Group PLC
28 February 2025
 

28 February 2025

Headlam Group plc

('Headlam', the 'Company', the 'Group')

 

Board Change

 

Headlam (LSE: HEAD), the UK's leading floorcoverings distributor, announces that, following a successful handover to Stephen Bird as part of the Company's Chair succession plan, Keith Edelman will step down from the Board with immediate effect and his roles as Chair of the Company and its Nomination Committee will pass to Stephen Bird.

 

Keith has been a Director of the Company for over six years and the Board is grateful to Keith for his service as both Non-Executive Director and, latterly as Chair, and wish him well for his future ventures.

 

The Board confirms that Stephen Bird will take over as Chair of the Company and its Nomination Committee with immediate effect, and Stephen will stand for re-election at the AGM in May 2025. The Board is also pleased to announce that Jemima Bird, Chair of our Remuneration Committee, has also been appointed as Senior Independent Director with immediate effect.

 

Chris Payne, Chief Executive Officer said "On behalf of the Board I would like to thank Keith for the extensive contribution he has made to the Company over the past six years, chairing the Board whilst we have made significant progress against our strategy and overseen our transformation plans. I'm pleased Stephen has agreed to be our Chair and Jemima our Senior Independent Director with immediate effect and look forward to continuing to work with both Stephen, Jemima and the rest of the Board as we implement our transformation plan".

 

 

This announcement is made in accordance with Listing Rule 6.4.6. No further details are required to be disclosed under LR6.4.8 or LR6.4.10.

 

 

 

Enquiries

Headlam Group plc

Tel: 01675 433 000

Chris Payne, Chief Executive

Email: headlamgroup@headlam.com

Adam Phillips, Chief Financial Officer

Alison Hughes, General Counsel & Company Secretary

 

Panmure Liberum Limited (Corporate Broker)

Tel: 020 3100 2000

Tom Scrivens / Atholl Tweedie

 

Peel Hunt LLP (Corporate Broker)

Tel: 020 7418 8900

George Sellar / Finn Nugent

Houston (Financial PR)

Tel: 020 4529 0549

Kate Hoare / Kelsey Traynor / Polly Clarke

 

Notes to Editors

Operating for over 30 years, Headlam is the UK's leading floorcoverings distributor. The Group works with suppliers across the globe manufacturing the broadest range of products, and gives them a highly effective route to market, selling their products into the large and diverse trade customer base. The Group has an extensive customer base spanning independent and multiple retailers, small and large contractors, and housebuilders. It provides its customers with a market leading service through the largest product range, in-depth knowledge, ecommerce and marketing support, and nationwide next day delivery service. To maximise customer reach and sales opportunity, Headlam operates businesses, trade brands and product brands across the UK and Continental Europe (France and the Netherlands), which are supported by the group's network, central resources and processes.

 

IMPORTANT NOTICE

This announcement has been issued by and is the sole responsibility of the Company. The information contained in this announcement is for background purposes and does not purport to be full or complete.

The information contained in this announcement is for background purposes only and no reliance may or should be placed by any person for any purpose whatsoever on the information contained in this announcement or on its completeness, accuracy or fairness. Recipients of this announcement should conduct their own investigation, evaluation and analysis of the business, data and property described in this announcement.

The information in this announcement is subject to change. This announcement is not intended to, and does not constitute or form part of, any offer to sell or issue or any solicitation of an offer to purchase, subscribe for, or otherwise acquire, any securities or a solicitation of any vote or approval in any jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAPAXAELSEFA
Date   Source Headline
25th Nov 20217:00 amRNSESG and Trading Update
24th Nov 20213:45 pmRNSOption Exercise and Transfer of Treasury Shares
10th Nov 202111:31 amRNSOption Exercise and Transfer of Treasury Shares
8th Nov 20211:26 pmRNSDirector/PDMR Shareholding
2nd Nov 202111:13 amRNSDirector/PDMR Shareholding
1st Nov 20212:29 pmRNSTotal Voting Rights
28th Oct 20211:32 pmRNSOption Exercise and Transfer of Treasury Shares
13th Oct 20214:08 pmRNSOption Exercise and Transfer of Treasury Shares
7th Oct 20217:00 amRNSDirectorate Change
30th Sep 20211:31 pmRNSTotal Voting Rights
29th Sep 20211:39 pmRNSOption Exercise and Transfer of Treasury Shares
24th Sep 20211:04 pmRNSDirector/PDMR Shareholding
15th Sep 20212:33 pmRNSOption Exercise and Transfer of Treasury Shares
2nd Sep 20214:02 pmRNSOption Exercise and Transfer of Treasury Shares
2nd Sep 20217:00 amRNSInterim Results
31st Aug 202111:11 amRNSTotal Voting Rights
18th Aug 20211:48 pmRNSOption Exercise and Transfer of Treasury Shares
4th Aug 20212:47 pmRNSOption Exercise and Transfer of Treasury Shares
2nd Aug 20211:07 pmRNSTotal Voting Rights
29th Jul 20217:00 amRNSPre-Close Trading Update
14th Jul 20211:18 pmRNSOption Exercise and Transfer of Treasury Shares
7th Jul 20211:53 pmRNSOption Exercise and Transfer of Treasury Shares
2nd Jul 20213:37 pmRNSOption Exercise and Transfer of Treasury Shares
1st Jul 20217:00 amRNSCapital Markets Day and Trading Update
30th Jun 202112:57 pmRNSTotal Voting Rights
23rd Jun 20219:45 amRNSOption Exercise and Transfer of Treasury Shares
22nd Jun 20217:00 amRNSAppointment of Non-Executive Director
9th Jun 20211:39 pmRNSOption Exercise and Transfer of Treasury Shares
1st Jun 202110:47 amRNSTotal Voting Rights
21st May 202112:51 pmRNSResult of AGM
21st May 20217:01 amRNSPublication of ESG Strategy Report
21st May 20217:00 amRNSAGM Trading Update
14th May 20217:00 amRNSAppointment of Non-Executive Director
12th May 20211:01 pmRNSOption Exercise and Transfer of Treasury Shares
30th Apr 20217:00 amRNSDisposal of Swiss Business
9th Apr 20212:28 pmRNSPerformance Share Plan awards
31st Mar 20214:50 pmRNSExercise of share options and TVR
24th Mar 202111:59 amRNSAnnual Report and Accounts and Notice of AGM
10th Mar 202111:56 amRNSDividend Payment Date
9th Mar 20217:00 amRNSFinal Results
1st Mar 20213:58 pmRNSTotal Voting Rights
2nd Feb 20213:36 pmRNSOption Exercise and Transfer of Treasury Shares.
1st Feb 20219:48 amRNSTotal Voting Rights
21st Jan 202112:19 pmRNSHolding(s) in Company
21st Jan 20217:00 amRNSTrading Update
6th Jan 202110:47 amRNSOption Exercise and Transfer of Treasury Shares
6th Jan 20217:00 amRNSCOVID-19 Operational Update
31st Dec 202011:31 amRNSTotal Voting Rights
22nd Dec 202011:31 amRNSOption Exercise and Transfer of Treasury Shares
16th Dec 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.